Overview
Infection of wound hematoma involves the accumulation of blood within a wound that becomes contaminated, potentially leading to localized or systemic infection. Prompt management is crucial to prevent complications such as sepsis and impaired wound healing 1.Diagnosis
Clinical signs include swelling, pain, warmth, and discoloration around the wound site.
Imaging (e.g., ultrasound) can help confirm hematoma presence and assess for complications like abscess formation.
Laboratory tests (CBC, ESR, CRP) may indicate systemic inflammatory response or infection 1.Management
First-line treatments:
- Irrigation and debridement of the wound to remove necrotic tissue and foreign material.
- Administration of broad-spectrum antibiotics tailored based on clinical suspicion and local resistance patterns.
Adjunctive treatments:
- Topical application of thrombin in patients receiving low-dose heparin to reduce hematoma formation, potentially decreasing infection risk 1.Special Populations
Low-dose heparin users: Topical thrombin may be beneficial in reducing hematoma formation without affecting coagulation parameters 1.Key Recommendations
Consider topical thrombin application in patients undergoing surgery who are on low-dose heparin prophylaxis to minimize hematoma formation and associated infection risk (Evidence: Moderate 1).
Perform thorough wound irrigation and debridement to manage hematoma and reduce infection risk (Evidence: Expert opinion).
Tailor antibiotic therapy based on clinical presentation and local microbiological data to effectively manage potential infections (Evidence: Expert opinion).References
1 Hashemi K, Donaldson LJ, Freeman JW, Sokhi GS, Gyde OH, Smith HV. The use of topical thrombin to reduce wound haematoma in patients receiving low-dose heparin. Current medical research and opinion 1981. link